Gabapentin NDC 65162-698

NDC codes

FDA NDC Directory

Product NDC (as listed)65162-698Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65162-0698Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65162-698-54	65162069854	50 CUP, UNIT-DOSE in 1 CARTON (65162-698-54) / 5 mL in 1 CUP, UNIT-DOSE (65162-698-39)Marketed from Sep 30, 2011
65162-698-90	65162069890	473 mL in 1 BOTTLE (65162-698-90)Marketed from Sep 30, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 250 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Amneal Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202024
Marketing start: Sep 30, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 65162-698_bcc054b1-a2fa-40b7-b150-b937763fcf7fSPL ID bcc054b1-a2fa-40b7-b150-b937763fcf7fSPL set ID 772d9e7a-3811-455a-99e6-f2a3d0769b9bRxCUI 283523UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465162069854 followed by a unit qualifier and the quantity

Package 65162-0698-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 13, 2025.

Indications (excerpt from the label)

Gabapentin oral solution is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin oral solution is indicated for: Postherpetic neuralgia in adults (1) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)